Those aiming for above-average market returns often engage in the meticulous process of stock picking. Choosing the right stocks can make a substantial difference in your wealth.
Relay Therapeutics Inc (NASDAQ: RLAY) closed the day trading at $5.96 down -2.45% from the previous closing price of $6.11. In other words, the price has decreased by -$2.45 from its previous closing price. On the day, 2.37 million shares were traded. RLAY stock price reached its highest trading level at $6.335 during the session, while it also had its lowest trading level at $5.93.
Ratios:
For a better understanding of RLAY, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 25.44 and its Current Ratio is at 25.44. In the meantime, Its Debt-to-Equity ratio is 0.07 whereas as Long-Term Debt/Eq ratio is at 0.06.
On April 19, 2023, Raymond James Upgraded its rating to Strong Buy which previously was Outperform but kept the price unchanged to $29.
On April 13, 2023, Raymond James started tracking the stock assigning a Outperform rating and target price of $29.Raymond James initiated its Outperform rating on April 13, 2023, with a $29 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Mar 27 ’24 when Bergstrom Donald A sold 765 shares for $7.70 per share. The transaction valued at 5,890 led to the insider holds 530,113 shares of the business.
Catinazzo Thomas sold 348 shares of RLAY for $2,680 on Mar 27 ’24. The Chief Financial Officer now owns 341,498 shares after completing the transaction at $7.70 per share. On Mar 27 ’24, another insider, Adams Brian, who serves as the Chief Legal Officer of the company, sold 348 shares for $7.70 each. As a result, the insider received 2,680 and left with 327,390 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, RLAY now has a Market Capitalization of 781826816 and an Enterprise Value of 85207040. For the stock, the TTM Price-to-Sale (P/S) ratio is 30.60 while its Price-to-Book (P/B) ratio in mrq is 1.01. Its current Enterprise Value per Revenue stands at 3.335 whereas that against EBITDA is -0.228.
Stock Price History:
The Beta on a monthly basis for RLAY is 1.72, which has changed by -0.5053942 over the last 52 weeks, in comparison to a change of 0.2006725 over the same period for the S&P500. Over the past 52 weeks, RLAY has reached a high of $13.32, while it has fallen to a 52-week low of $5.95. The 50-Day Moving Average of the stock is -31.12%, while the 200-Day Moving Average is calculated to be -36.92%.
Shares Statistics:
Over the past 3-months, RLAY traded about 1.21M shares per day on average, while over the past 10 days, RLAY traded about 1337210 shares per day. A total of 127.46M shares are outstanding, with a floating share count of 92.21M. Insiders hold about 29.71% of the company’s shares, while institutions hold 71.74% stake in the company. Shares short for RLAY as of 1711584000 were 11172603 with a Short Ratio of 9.25, compared to 1709164800 on 10995741. Therefore, it implies a Short% of Shares Outstanding of 11172603 and a Short% of Float of 10.96.
